The Role of Viral Infections in Exacerbations of Chronic Obstructive Pulmonary Disease and Asthma

Overview

Journal Ther Adv Respir Dis

Publisher Sage Publications

Specialties Pharmacology
Pulmonary Medicine

Date 2015 Nov 28

PMID 26611907

Citations 88

Authors

Richard Hewitt

Hugo Farne

Andrew Ritchie

Emma Luke

Sebastian L Johnston

Patrick Mallia

Affiliations

Soon will be listed here.

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are major causes of global morbidity and mortality worldwide. The clinical course of both asthma and COPD are punctuated by the occurrence of exacerbations, acute events characterized by increased symptoms and airflow obstruction. Exacerbations contribute most of the morbidity, mortality and excess healthcare costs associated with both asthma and COPD. COPD and asthma exacerbations are frequently associated with respiratory virus infections and this has led to an intense research focus into the mechanisms of virus-induced exacerbations over the past decade. Current therapies are effective in reducing chronic symptoms but are less effective in preventing exacerbations, particularly in COPD. Understanding the mechanisms of virus-induced exacerbation will lead to the development of new targeted therapies that can reduce the burden of virus-induced exacerbations. In this review we discuss current knowledge of virus-induced exacerbations of asthma and COPD with a particular focus on mechanisms, human studies, virus-bacteria interactions and therapeutic advances.

Citing Articles

Social vulnerability and asthma-related emergency medical services in Illinois.

Geiger S, Khaium M, Gustafson E, Shapiro M, Keeley S, Johnson C Front Public Health. 2025; 13:1521545.

PMID: 40078769 PMC: 11897263. DOI: 10.3389/fpubh.2025.1521545.

Infectious diseases, cardio-cerebrovascular health and vaccines: pathways to prevention.

Ecarnot F, Amuthavalli Thiyagarajan J, Barbagallo M, Barratt J, Biering-Sorensen T, Botelho-Nevers E Aging Clin Exp Res. 2025; 37(1):80.

PMID: 40074946 PMC: 11903628. DOI: 10.1007/s40520-025-02968-y.

Incidence of acute exacerbations of chronic respiratory disease during pulmonary rehabilitation delivered at home or hospital.

Burge A, Cox N, Ponnudurai A, Holland A, Bondarenko J, Hill C ERJ Open Res. 2025; 11(1).

PMID: 40008175 PMC: 11849134. DOI: 10.1183/23120541.00209-2024.

Evaluation of intranasal TLR2/6 agonist INNA-051: safety, tolerability and proof of pharmacology.

Mercuri F, White S, McQuilten H, Lemech C, Mynhardt S, Hari R ERJ Open Res. 2024; 10(6).

PMID: 39655168 PMC: 11626610. DOI: 10.1183/23120541.00199-2024.

Interplay between Lung Diseases and Viral Infections: A Comprehensive Review.

Suri C, Pande B, Suhasini Sahithi L, Sahu T, Verma H Microorganisms. 2024; 12(10).

PMID: 39458339 PMC: 11510474. DOI: 10.3390/microorganisms12102030.

References

Zhu Z, Tang W, Gwaltney Jr J, Wu Y, Elias J . Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am J Physiol. 1997; 273(4):L814-24. DOI: 10.1152/ajplung.1997.273.4.L814. View

Baines K, Hsu A, Tooze M, Gunawardhana L, Gibson P, Wark P . Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. Respir Res. 2013; 14:15. PMC: 3570361. DOI: 10.1186/1465-9921-14-15. View

Contoli M, Ito K, Padovani A, Poletti D, Marku B, Edwards M . Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy. 2015; 70(8):910-20. DOI: 10.1111/all.12627. View

Sykes A, Macintyre J, Edwards M, Del Rosario A, Haas J, Gielen V . Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax. 2013; 69(3):240-6. DOI: 10.1136/thoraxjnl-2012-202909. View

Message S, Laza-Stanca V, Mallia P, Parker H, Zhu J, Kebadze T . Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A. 2008; 105(36):13562-7. PMC: 2528869. DOI: 10.1073/pnas.0804181105. View

Ishizuka S, Yamaya M, Suzuki T, Takahashi H, Ida S, Sasaki T . Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. J Infect Dis. 2003; 188(12):1928-39. DOI: 10.1086/379833. View

Ieki K, Matsukura S, Kokubu F, Kimura T, Kuga H, Kawaguchi M . Double-stranded RNA activates RANTES gene transcription through co-operation of nuclear factor-kappaB and interferon regulatory factors in human airway epithelial cells. Clin Exp Allergy. 2004; 34(5):745-52. DOI: 10.1111/j.1365-2222.2004.1941.x. View

Singh M, Lee S, Porter P, Xu C, Ohno A, Atmar R . Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2010; 125(6):1369-1378.e2. PMC: 2881843. DOI: 10.1016/j.jaci.2010.02.035. View

Hurst J, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R . Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010; 363(12):1128-38. DOI: 10.1056/NEJMoa0909883. View

10.

Santa-Olalla Peralta P, Cortes-Garcia M, Vicente-Herrero M, Castrillo-Villamandos C, Arias-Bohigas P, Pachon-del Amo I . Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April - December 2009. Euro Surveill. 2010; 15(38). DOI: 10.2807/ese.15.38.19667-en. View

11.

Johnston S, Pattemore P, SANDERSON G, Smith S, Lampe F, Josephs L . Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995; 310(6989):1225-9. PMC: 2549614. DOI: 10.1136/bmj.310.6989.1225. View

12.

Papadopoulos N, Bates P, Bardin P, Papi A, Leir S, Fraenkel D . Rhinoviruses infect the lower airways. J Infect Dis. 2000; 181(6):1875-84. DOI: 10.1086/315513. View

13.

Rohde G, Wiethege A, Borg I, Kauth M, Bauer T, Gillissen A . Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003; 58(1):37-42. PMC: 1746460. DOI: 10.1136/thorax.58.1.37. View

14.

Bochkov Y, Hanson K, Keles S, Brockman-Schneider R, Jarjour N, Gern J . Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 2009; 3(1):69-80. PMC: 2884103. DOI: 10.1038/mi.2009.109. View

15.

Sonnenfeld G, HUDGENS R . Effect of sidestream and mainstream smoke exposure on in vitro interferon-alpha/beta production by L-929 cells. Cancer Res. 1986; 46(6):2779-83. View

16.

Edwards M, Haas J, Panettieri Jr R, Johnson M, Johnston S . Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements. J Biol Chem. 2007; 282(21):15366-75. DOI: 10.1074/jbc.M701325200. View

17.

Arden K, Chang A, Lambert S, Nissen M, Sloots T, Mackay I . Newly identified respiratory viruses in children with asthma exacerbation not requiring admission to hospital. J Med Virol. 2010; 82(8):1458-61. DOI: 10.1002/jmv.21819. View

18.

Khetsuriani N, Kazerouni N, Erdman D, Lu X, Redd S, Anderson L . Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol. 2006; 119(2):314-21. PMC: 7112359. DOI: 10.1016/j.jaci.2006.08.041. View

19.

Beckham J, Cadena A, Lin J, Piedra P, Glezen W, Greenberg S . Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect. 2005; 50(4):322-30. PMC: 7132437. DOI: 10.1016/j.jinf.2004.07.011. View

20.

Bossios A, Psarras S, Gourgiotis D, Skevaki C, Constantopoulos A, Saxoni-Papageorgiou P . Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells. Respir Res. 2005; 6:114. PMC: 1283981. DOI: 10.1186/1465-9921-6-114. View